Welcome to the CytomX Therapeutics fourth-quarter 2024 and financial results call. Please be advised that today's call is being recorded. I would now like to hand the call over to your host for today, ...

The European Commission approved Opdivo plus Yervoy for first-line treatment of advanced liver cancer, citing significant ...

Scientists have uncovered the mechanism by which aspirin stimulates the immune system and can reduce the metastasis of some ...

Continued progress with lead program, CX-2051 (EpCAM PROBODY® Topo-1 ADC), in Phase 1a study in advanced colorectal cancer with initial Phase 1a clinical data to be presented in 1H 2025 - - CX-801 ...

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...

Jennie Garth slams the Oscars’ in memoriam segment for Shannen Doherty snub - The late ‘Beverly Hills, 90210’ star was ...

In 2009, I began medical school. When I received my medical doctorate degree in 2013, I thought I was already a doctor, only ...

Delcath Systems, Inc. ( ($DCTH) ) has released its Q4 earnings. Here is a breakdown of the information Delcath Systems, Inc. presented to its ...

AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), ...

A new study found that aspirin may help prevent some cancers from spreading by enhancing the immune system's ability to attack metastatic cells.

With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but ...

Ipsen's 2024 dividend per share amounted to EUR 1.20. We view Ipsen's shareholder distributions as mixed as many other biotechnology companies under our coverage do not pay dividends. We anticipate ...